Sugi Predict

Sugi Predict / Compounds / SCHEMBL20528447

SCHEMBL20528447

SCHEMBL20528447

CS(=O)(=O)OC(CCC(F)(F)F)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP24A1 Q07973 1/20 0.38
▸ SLC6A4 P31645 6/20 0.37
▸ SLC6A2 P23975 4/20 0.37
▸ SLC6A3 Q01959 4/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ LMNA P02545 4/20 0.37
▸ HRH3 Q9Y5N1 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ MTOR P42345 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ KCNK2 O95069 2/20 0.37
▸ KCNH2 Q12809 2/20 0.37
▸ CACNA1C Q13936 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ HTR2C P28335 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20818660 0.85 CYP24A1 (0.36) CYP24A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL14661502 0.84 GRIA4 (0.39) KMT2ARAB9ATSHRMAPK1ALDH1A1
SCHEMBL12789462 0.80 SLC6A4 (0.35) CYP24A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL2073576 0.80 CYP24A1 (0.37) CYP24A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL12933943 0.80 CYP24A1 (0.37) CYP24A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL7774939 0.79 POLB (0.41) CYP24A1SLC6A4KDM4EALDH1A1SMN1; SMN2
SCHEMBL8126233 0.78 LMNA (0.41) CYP24A1SLC6A4MEN1KMT2ALMNA
SCHEMBL8617087 0.77 GSR (0.41) CYP24A1SLC6A4LMNACYP2D6CYP2C19
SCHEMBL8411474 0.77 SLC6A4 (0.59) SLC6A4SLC6A2SLC6A3MEN1KMT2A
SCHEMBL8623628 0.77 CYP2C19 (0.41) CYP2D6CYP2C19CYP3A4CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108290881-B Therapeutic compounds and methods of use thereof 健泰科生物技术公司 2021-12-07 — — CN disclosed
US-20210171516-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2021-06-10 — — US disclosed
US-10787446-B2 Therapeutic compounds and methods of use thereof GENENTECH, INC. (US) 2020-09-29 — — US disclosed
US-10787446-B2 Therapeutic compounds and methods of use thereof GENENTECH, INC. (US) 2020-09-29 — — US disclosed
US-20180291014-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180291014-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF AVPR1B, C3AR1, RHEB CYP24A1 1763/4885SLC6A4 2301/4885SLC6A2 1166/4885
US-10787446-B2 Therapeutic compounds and methods of use thereof AVPR1B, C3AR1, RHEB CYP24A1 1763/4885SLC6A4 2301/4885SLC6A2 1166/4885
US-20210171516-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF AVPR1B, C3AR1, RHEB CYP24A1 1763/4885SLC6A4 2301/4885SLC6A2 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.